underwriting rules and regulations and assist with training. Qualifications: Higher Certificate in Short-term Insurance RE 5... Advantageous Tertiary qualification (Bcom degree or similar) Experience: 5 – 7 years’ experience in short term Insurance...
JOB PURPOSE Facilitate the retaining of policies through company approved retention strategies. Focus on maintaining customer relationships, meeting various KPIs and troubleshooting specific customer problems. Has a solid knowledge of pro...
in the Banking, Insurance, Asset Management and Funds industries. As a BDO Financial Services professional, you’ll work..., funds and insurance companies; Hands on experience with clients and management; Open door policy with managers...
are in order, making sure there are no Reflags All the client premiums are up to-date. Prepare insurance claim forms or related... or other involved persons to obtain missing information. Review insurance policy to determine coverage. Organize or work with detailed...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »